Our findings demonstrated that circTRHDE might be a target for infantile pneumonia treatment, which relieved LPS-induced cell inflammatory injury by the regulation of the miR-318-3p/TRAF3 axis.
CircTRHDE knockdown protects WI-38 cells against LPS-induced inflammatory injury.